Santhera Pharmaceuticals Holding AG (LON:0QN1)

LON:0QN1 Statistics

Total Valuation

LON:0QN1 has a market cap or net worth of GBP 197.16 million. The enterprise value is 218.85 million.

Market Cap	197.16M
Enterprise Value	218.85M

Important Dates

The next estimated earnings date is Monday, April 27, 2026.

Earnings Date	Apr 27, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	13.93M
Shares Outstanding	n/a
Shares Change (YoY)	+9.97%
Shares Change (QoQ)	+11.74%
Owned by Insiders (%)	2.34%
Owned by Institutions (%)	3.16%
Float	11.01M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.38
PB Ratio	-83.82
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-3.64
EV / Sales	4.70
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.81

Financial Position

The company has a current ratio of 1.02

Current Ratio	1.02
Quick Ratio	0.51
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-1.00
Interest Coverage	-5.95

Financial Efficiency

Return on equity (ROE) is -288.14% and return on invested capital (ROIC) is -250.98%.

Return on Equity (ROE)	-288.14%
Return on Assets (ROA)	-26.60%
Return on Invested Capital (ROIC)	-250.98%
Return on Capital Employed (ROCE)	-69.68%
Weighted Average Cost of Capital (WACC)	2.87%
Revenue Per Employee	569,448
Profits Per Employee	-761,452
Employee Count	79
Asset Turnover	0.41
Inventory Turnover	2.65

Taxes

In the past 12 months, LON:0QN1 has paid 195,489 in taxes.

Income Tax	195,489
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -2.58% in the last 52 weeks. The beta is -0.72, so LON:0QN1's price volatility has been lower than the market average.

Beta (5Y)	-0.72
52-Week Price Change	-2.58%
50-Day Moving Average	12.80
200-Day Moving Average	12.64
Relative Strength Index (RSI)	76.33
Average Volume (20 Days)	8,336

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LON:0QN1 had revenue of GBP 44.99 million and -60.15 million in losses. Loss per share was -4.97.

Revenue	44.99M
Gross Profit	6.03M
Operating Income	-46.67M
Pretax Income	-59.96M
Net Income	-60.15M
EBITDA	-41.88M
EBIT	-46.67M
Loss Per Share	-4.97

Balance Sheet

The company has 16.88 million in cash and 37.83 million in debt, with a net cash position of -20.95 million.

Cash & Cash Equivalents	16.88M
Total Debt	37.83M
Net Cash	-20.95M
Net Cash Per Share	n/a
Equity (Book Value)	-2.35M
Book Value Per Share	-0.18
Working Capital	937,064

Cash Flow

In the last 12 months, operating cash flow was -37.48 million and capital expenditures -203,749, giving a free cash flow of -37.69 million.

Operating Cash Flow	-37.48M
Capital Expenditures	-203,749
Free Cash Flow	-37.69M
FCF Per Share	n/a

Margins

Gross margin is 13.41%, with operating and profit margins of -103.75% and -133.72%.

Gross Margin	13.41%
Operating Margin	-103.75%
Pretax Margin	-133.28%
Profit Margin	-133.72%
EBITDA Margin	-93.09%
EBIT Margin	-103.75%
FCF Margin	n/a

Dividends & Yields

LON:0QN1 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.97%
Shareholder Yield	-9.97%
Earnings Yield	-30.51%
FCF Yield	-19.12%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 3, 2023. It was a reverse split with a ratio of 0.1.

Last Split Date	Jul 3, 2023
Split Type	Reverse
Split Ratio	0.1

Scores

LON:0QN1 has an Altman Z-Score of -7.25 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-7.25
Piotroski F-Score	2